Physician

Adedeji Oluwatosin Sodeinde, M.D.

According to 2025 Medicare claims, Adedeji Sodeinde, M.D. (NPI: 1982047205) practices nephrology in the Cleveland, OH market, with the plurality of this provider's patient population coming from Lorain, OH. This provider's primary affiliated billing organization is NORTH COAST NEPHROLOGY, INC (NPI: 1871529321; TIN: 341898754) and primary practice location at 44035-5902. Sodeinde is affiliated with the Mercy Health Select, LLC (ACO ID: A1215), participating under the MSSP model.

Sodeinde's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 327 traditional Medicare patients, billed 1,434 HCPCS/CPT codes, and received $132,568 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 603 prescription claims across 145 beneficiaries totaling $34,726 in drug costs, led by Farxiga (Dapagliflozin Propanediol). 2016 DME data shows 12 claims. Open Payments data shows 4 records totaling $59. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $80,267 to $34,726. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	239	771	$52,813
2019	469	1,675	$122,287
2020	425	1,447	$113,895
2021	457	1,647	$138,060
2022	430	1,599	$144,060
2023	381	1,338	$126,748
2024	327	1,434	$132,568

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	84	1,594	$80,267
2016	53	314	$15,788
2017	11	22	$168
2018	33	86	$1,703
2019	85	280	$13,322
2020	97	426	$10,391
2021	122	521	$15,612
2022	142	771	$21,894
2023	134	616	$38,184
2024	145	603	$34,726

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	39	$1,630
2016	N/R	12	$517
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	128	149	$139
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	37	74	$95
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	83	145	$86
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	179	707	$63
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	75	102	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Farxiga	Dapagliflozin Propanediol	15	660	$12,969
Jardiance	Empagliflozin	17	510	$9,401
Torsemide	Torsemide	43	2,252	$967
Hydralazine Hcl	Hydralazine Hcl	75	4,044	$543
Potassium Chloride	Potassium Chloride	30	1,898	$534

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$59	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adedeji Oluwatosin Sodeinde, M.D.?

Tedicare shows public-source Medicare data for Adedeji Oluwatosin Sodeinde, M.D. (NPI 1982047205), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adedeji Oluwatosin Sodeinde, M.D. have ACO affiliation data?

Adedeji Oluwatosin Sodeinde, M.D. is shown with ACO affiliation data for Mercy Health Select, LLC (MSSP, ACO ID A1215).

What billing organization is linked to Adedeji Oluwatosin Sodeinde, M.D.?

Adedeji Oluwatosin Sodeinde, M.D. is linked to NORTH COAST NEPHROLOGY, INC (billing NPI 1871529321) in the available physician profile data.

Does Adedeji Oluwatosin Sodeinde, M.D. have Open Payments data?

Adedeji Oluwatosin Sodeinde, M.D. has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.